Mackenzie Financial Corp Has $226.34 Million Holdings in McKesson Corporation $MCK

Key Points

• Mackenzie Financial cut its stake in McKesson by 16.4% in Q3, now holding 292,975 shares valued at about $226.34 million (≈0.24% of the company).
• McKesson beat quarterly estimates with $9.34 EPS vs. $9.19 expected and $106.16 billion revenue (up 11.4% year-over-year), and set FY2026 guidance of 38.80–39.20 EPS; the company has a market cap of ~$113.74 billion and a P/E of 26.71.
• Company insiders sold 3,868 shares (~$3.74 million) over the last quarter (insiders own 0.08%), and McKesson declared a quarterly dividend of $0.82 (annualized $3.28, ~0.4% yield) with an ex-dividend date of March 2.

Mackenzie Financial Corp decreased its stake in shares of McKesson Corporation (NYSE:MCK - Free Report) by 16.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 292,975 shares of the company's stock after selling 57,382 shares during the quarter. Mackenzie Financial Corp owned about 0.24% of McKesson worth $226,335,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC boosted its position in shares of McKesson by 46.3% during the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP bought a new stake in McKesson in the 1st quarter valued at about $233,000. Sivia Capital Partners LLC boosted its holdings in McKesson by 77.9% in the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock worth $502,000 after acquiring an additional 300 shares in the last quarter. Penserra Capital Management LLC grew its stake in McKesson by 8.5% in the second quarter. Penserra Capital Management LLC now owns 690 shares of the company's stock valued at $504,000 after acquiring an additional 54 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in shares of McKesson by 5,743.6% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 28,809 shares of the company's stock valued at $21,111,000 after acquiring an additional 28,316 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company's stock.

Insider Buying and Selling

In other McKesson news, Director Maria Martinez sold 349 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $939.87, for a total value of $328,014.63. Following the transaction, the director owned 301 shares in the company, valued at approximately $282,900.87. The trade was a 53.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the company's stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares of the company's stock, valued at approximately $1,851,096.24. This represents a 10.85% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 3,868 shares of company stock valued at $3,743,820 over the last quarter. Company insiders own 0.08% of the company's stock.

McKesson Trading Down 1.4%

McKesson stock opened at $928.60 on Wednesday. McKesson Corporation has a 12 month low of $635.00 and a 12 month high of $999.00. The business's 50 day simple moving average is $886.79 and its 200 day simple moving average is $820.88. The company has a market cap of $113.74 billion, a price-to-earnings ratio of 26.71, a PEG ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm's quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the previous year, the business earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities research analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson's payout ratio is 9.43%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on MCK shares. Weiss Ratings cut McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a report on Thursday, February 5th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a report on Wednesday, January 14th. JPMorgan Chase & Co. lifted their price objective on shares of McKesson from $983.00 to $1,107.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. Morgan Stanley reissued an "overweight" rating and set a $966.00 target price on shares of McKesson in a research report on Thursday, January 29th. Finally, Barclays raised their price target on shares of McKesson from $960.00 to $1,050.00 and gave the company an "overweight" rating in a research report on Wednesday, February 18th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $960.93.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.